218 related articles for article (PubMed ID: 36739298)
1. Clinical and sonographic impact of oral contraception in patients with deep endometriosis and adenomyosis at 2 years of follow-up.
Carrillo Torres P; Martínez-Zamora MÁ; Ros C; Rius M; Mensión E; Gracia M; Carmona F
Sci Rep; 2023 Feb; 13(1):2066. PubMed ID: 36739298
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Quality of Life, Sexual Quality of Life, and Pain Symptoms in Deep Infiltrating Endometriosis Patients With or Without Associated Adenomyosis and the Influence of a Flexible Extended Combined Oral Contraceptive Regimen: Results of a Prospective, Observational Study.
Alcalde AM; Martínez-Zamora MÁ; Gracia M; Ros C; Rius M; Castelo-Branco C; Carmona F
J Sex Med; 2022 Feb; 19(2):311-318. PubMed ID: 34974988
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of endometriosis and adenomyosis at transvaginal ultrasound examination in symptomatic women.
Orlov S; Jokubkiene L
Acta Obstet Gynecol Scand; 2022 May; 101(5):524-531. PubMed ID: 35224723
[TBL] [Abstract][Full Text] [Related]
4. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
[TBL] [Abstract][Full Text] [Related]
5. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
[TBL] [Abstract][Full Text] [Related]
6. Surgery vs. hormone-based treatment for pain control in deep infiltrating endometriosis: a retrospective cohort study.
Rezende GP; Venturini MC; Kawagoe LN; Yela Gomes DA; Benetti-Pinto CL
Curr Med Res Opin; 2022 Apr; 38(4):641-647. PubMed ID: 35060442
[TBL] [Abstract][Full Text] [Related]
7. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
Caruso S; Iraci M; Cianci S; Fava V; Casella E; Cianci A
J Endocrinol Invest; 2016 Aug; 39(8):923-31. PubMed ID: 27023105
[TBL] [Abstract][Full Text] [Related]
8. Hormone treatment as first line therapy is safe and relieves pelvic pain in women with bowel endometriosis.
Andres MP; Mendes RFP; Hernandes C; Araújo SEA; Podgaec S
Einstein (Sao Paulo); 2019 May; 17(2):eAO4583. PubMed ID: 31066795
[TBL] [Abstract][Full Text] [Related]
9. Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence.
Jensen JT; Schlaff W; Gordon K
Fertil Steril; 2018 Jul; 110(1):137-152.e1. PubMed ID: 29937152
[TBL] [Abstract][Full Text] [Related]
10. Adenomyosis and endometriosis in adolescents and young women with pelvic pain: prevalence and risk factors.
Zannoni L; Del Forno S; Raimondo D; Arena A; Giaquinto I; Paradisi R; Casadio P; Meriggiola MC; Seracchioli R
Minerva Pediatr (Torino); 2024 Feb; 76(1):57-63. PubMed ID: 32549030
[TBL] [Abstract][Full Text] [Related]
11. Combined oral contraceptive therapy in women with posterior deep infiltrating endometriosis.
Mabrouk M; Frascà C; Geraci E; Montanari G; Ferrini G; Raimondo D; Alvisi S; Paradisi R; Villa G; Seracchioli R
J Minim Invasive Gynecol; 2011; 18(4):470-4. PubMed ID: 21777836
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal Retraction Pocket Defects and Their Important Relationship with Pelvic Pain and Endometriosis.
Carranco RC; Zomer MT; Berg CF; Smith AV; Koninckx P; Kondo W
J Minim Invasive Gynecol; 2021 Feb; 28(2):168-169. PubMed ID: 32474173
[TBL] [Abstract][Full Text] [Related]
13. Hormonal contraception in women with endometriosis: a systematic review.
Grandi G; Barra F; Ferrero S; Sileo FG; Bertucci E; Napolitano A; Facchinetti F
Eur J Contracept Reprod Health Care; 2019 Feb; 24(1):61-70. PubMed ID: 30664383
[TBL] [Abstract][Full Text] [Related]
14. Assessment of levator hiatal area using 3D/4D transperineal ultrasound in women with deep infiltrating endometriosis and superficial dyspareunia treated with pelvic floor muscle physiotherapy: randomized controlled trial.
Del Forno S; Arena A; Pellizzone V; Lenzi J; Raimondo D; Cocchi L; Paradisi R; Youssef A; Casadio P; Seracchioli R
Ultrasound Obstet Gynecol; 2021 May; 57(5):726-732. PubMed ID: 33428320
[TBL] [Abstract][Full Text] [Related]
15. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis.
Muzii L; Di Tucci C; Achilli C; Di Donato V; Musella A; Palaia I; Panici PB
Am J Obstet Gynecol; 2016 Feb; 214(2):203-211. PubMed ID: 26364832
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of endometriosis-related pain among women seeking hormonal contraception.
Vannuccini S; Biagiotti C; Esposto MC; La Torre F; Clemenza S; Orlandi G; Capezzuoli T; Petraglia F
Gynecol Endocrinol; 2022 May; 38(5):398-402. PubMed ID: 35238265
[TBL] [Abstract][Full Text] [Related]
17. Endometrial thickness in the evaluation of clinical response to medical treatment for deep infiltrating endometriosis: a retrospective study.
Mariani LL; Mancarella M; Fuso L; Baino S; Biglia N; Menato G
Arch Gynecol Obstet; 2021 Jan; 303(1):161-168. PubMed ID: 32926208
[TBL] [Abstract][Full Text] [Related]
18. Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study.
Niu X; Luo Q; Wang C; Zhu L; Huang L
Medicine (Baltimore); 2021 Feb; 100(6):e24597. PubMed ID: 33578561
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives for pain associated with endometriosis.
Brown J; Crawford TJ; Datta S; Prentice A
Cochrane Database Syst Rev; 2018 May; 5(5):CD001019. PubMed ID: 29786828
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
